Comparative statistics by cancer registry
Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
(The Gambia, 1993-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
Site | ICD-10 | No. of cases | Male | Female | Number of cases by age group | Relative survival by age group | ||||||||||||
5-year survival | 5-year survival | |||||||||||||||||
No. | Abs | Rel | No. | Abs | Rel | <45 | 45-54 | 55-64 | 65-74 | 75+ | <45 | 45-54 | 55-64 | 65-74 | 75+ | |||
C16 | Stomach | 39 | 17 | 20.0 | 21.2 | 22 | 10 | 3 | 11 | 11 | 4 | 13.6 | 0.0 | 0.0 | 0.0 | 0.0 | ||
C22 | Liver | 123 | 91 | 2.1 | 2.2 | 32 | 50 | 27 | 26 | 15 | 5 | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | ||
C33-34 | Lung | 31 | 27 | 16.0 | 28.8 | 4 | 100.0 | 106.2 | 5 | 8 | 7 | 8 | 3 | 0.0 | 56.5 | 0.0 | 0.0 | 126.2 |
C50 | Breast | 61 | 2 | 59 | 9.7 | 10.8 | 26 | 18 | 9 | 5 | 3 | 16.3 | 0.0 | 0.0 | 35.5 | 0.0 | ||
C53 | Cervix | 202 | 202 | 22.4 | 23.6 | 109 | 45 | 26 | 18 | 4 | 26.4 | 20.2 | 22.5 | 13.2 | 0.0 | |||
C82-85+C96 | Non-Hodgkin lymphoma | 49 | 30 | 17.9 | 18.6 | 19 | 37.8 | 39.2 | 32 | 7 | 4 | 4 | 2 | 27.7 | 29.9 | 0.0 | 0.0 | 0.0 |
Graphs:
Other tables available for this registry:
- Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (The Gambia, 1993-1997 cases followed-up until 1999) |
- Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (The Gambia, 1993-1997 cases followed-up until 1999) |
- Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (The Gambia, 1993-1997 cases followed-up until 1999) |
- Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (The Gambia, 1993-1997 cases followed-up until 1999) |
Registry chapter:
Consult the chapter in Cancer survival in developping countries (Volume II) |